Heterotrimeric G proteins are signaling switches typically activated by GPCRs, the largest family of druggable targets in the human genome. But, what happens when G protein signaling is triggered by proteins that are not GPCRs? Mechanisms, consequences, and opportunities for pharmacological targeting of these underappreciated signaling processes will be presented